Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Biomarkers Market to Register 15.3% CAGR as Demand for Cancer Biomarkers Increases by 17.1%

Published

on

 

Need for Early Disease Diagnosis to Push Biomarkers Market Past US$ 278 Bn by 2032

In the latest study, Fact.MR offers a comprehensive analysis on the global biomarkers market for the upcoming decade. The report also explicates the key factors such as growth drivers, opportunities, and trends across multiple segments including disease type, type, and application across seven major regions.

NEW YORKMarch 30, 2022 /PRNewswire/ — Fact.MR – A Market Research and Competitive Intelligence Provider: The overall sales of biomarkers were valued at around US$ 59.1 Bn in 2021. According to Fact.MR, the biomarkers market is expected to reach a valuation of US$ 278 Bn, exhibiting growth at a CAGR of 15.3% between 2022 and 2032.

Biomarkers are increasingly used for the diagnosis of cancer, especially across the U.S., India and Japan. According to the American Cancer Society report, around 609,640 people succumbed to cancer in the U.S and over 1.9 million new cancer cases were diagnosed worldwide in 2021. Hence, to curb the global burden, the demand for biomarkers is estimated to rise in the coming years.

Also, rising use of biomarkers in validation and development of personalized medicines will create remunerative prospects for the growth in the market. Moreover, increasing number of people at a risk of developing chronic diseases like neurological disorders, cardiovascular disease, and kidney disorders is likely to promote the sales of biomarkers.

For Critical Insights on this Market, Request for More Info at:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7181

Advancements in genomics has helped biopharmaceutical researchers to focus on identifying biomarkers such as the HER2 positive gene mutation. Such findings are expected to aid the development of personalized treatments, thereby, propelling the demand for biomarkers.

In addition to this, rising use of biomarkers to quantify the susceptibility of an individual to various diseases is pushing the demand for molecular biomarkers. This is likely to create lucrative sales prospects for biomarkers.

Further, pharmaceutical companies are using biomarkers on a large scale to analyze and discover novel drug. This is due to the increasing demand for efficient and cost effective treatment dose. Hence, the rising need for new drugs is likely to boost the market.

Subsequently, the use of DNA fingerprinting technology is gaining immense traction in the countries such as India, the U.S., and the U.K. It is extensively used to identify criminals through the unique DNA patterns. Such technological advancements are projected to augment the sales in the market.

Report Attributes

Details

Base Year Value (2021A)

US$ 59.1 Bn

Projected Year Value (2032F)

US$ 278 Bn

Global Growth Rate (2022-2032)

CAGR 15.3%

Key Takeaways:

  • Based on type, the safety segment is estimated to register growth at 15.9% CAGR during the forecast period.
  • In terms of disease type, the cancer segment is projected to exhibit growth at 17.1% CAGR during 2022-2032.
  • Asia Pacific is anticipated to record fastest growth rate owing to increasing use of biomarkers in personalized medicines.
  • The U.S. is anticipated to dominate the market owing to the increasing research and development activities in the molecular biomarkers.
  • Japan biomarkers market is projected to witness fastest growth in East Asia, registering 17.2% CAGR.

Growth Drivers:

  • Increasing use of biomarkers to assess the effectiveness of the drug is projected to spur the sales of biomarkers.
  • Integration of advanced data management technology and key imaging in biomarkers for early diagnosis of cancer will create lucrative opportunities for the market.

Restraints:

  • The lengthy timelines for validating biomarkers is likely to hinder the growth in the market.
  • High capital investments in the development due to the need for extensive clinical validation will limit the sales of biomarkers in the coming years.

To Gain In-Depth Insights on Biomarkers Market, Request Methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=7181

Competitive Landscape:

Key players operating in the global biomarkers market are advancing their technologies and manufacturing capabilities to update their product line. They are also focusing on expanding their consumer base through introducing advanced products for early diagnoses of chronic diseases.

Besides this, some of the organizations are also adopting new strategies such as collaborations, joint ventures, contract, and acquisitions to strengthen their global footprint.

For instance,

  • July 2020: Chugai and Thermo Fisher Scientific signed an agreement with the goal of commercialization oncomin Dx targeted tests for use in patients with non-small cell lung cancer (NSCLC). They also plan to expand the use of other local biomarker tests.
  • April, 2021: F. Hoffmann La Roche Ltd. Introduced two cardiac biomarker tests, the N-Terminal Pro Brain Sodium Diuretic Peptide Test (NTproBNP) and the Sensitive Cardiac Troponin T (cTnThs). These biomarker tests help in the management of cardiovascular diseases by helping the doctors diagnose heart attacks and manage heart failure.

Key Companies Profiled by Fact.MR

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers AG
  • Epigenetics AG
  • General Electric
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Johnson & Johnson Services, Inc.
  • Qiagen

More Valuable Insights on Biomarkers Market

In the latest report, Fact.MR provides a detailed market study on the global biomarkers market for the forecast period of 2022 to 2032. The report also offers key factors expected to shape the future growth prospects of the biomarkers market with detailed segmentation as follows:

By Disease Type:

  • Cardiovascular Diseases
  • Cancer
  • Neurological Diseases
  • Immunological Diseases
  • Other Disease Types

By Type:

  • Safety
  • Efficacy
  • Validation

By Application:

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania (SAO)
  • Middle East & Africa (MEA)

To Remain ‘Ahead’ of Your Competitors, Buy the Report Now!

https://www.factmr.com/checkout/7181

Key Questions Covered in Biomarkers Market Report

  • What was market size of the global biomarkers market in 2021?
  • What is the anticipated growth rate of the global biomarkers market during 2022-2032?
  • Which are the factors driving the growth of the biomarkers market?
  • What is the estimated market value of biomarkers market during the forecast period?
  • Who are the prominent biomarkers manufacturers?
  • What was growth rate of the global biomarkers market during 2017-2021?

Explore Fact.MR’s Coverage on the Healthcare Domain –

Cancer Biomarkers Market Trends: Rising incidence of debilitating cancers are fueling the demand for cancer biomarkers. In addition to this, growing preference toward personalized medicine for cancer treatment owing to absence of standard diagnosis and treatment will further bolster the growth in the market.

Vocal Biomarker Market Growth: Use of vocal patterns by clinical psychologists and psychoanalysts to analyze personality traits of patients is projected to increase the sales of vocal biomarker. Also, the ability of the vocal biomarkers in remote health monitoring is likely to create remunerative prospects for the market.

Tuberculosis Biomarkers Market Forecast: Increasing mortality rates due to tuberculosis and the emergence of multidrug-resistant tuberculosis is projected to increase the demand for tuberculosis biomarkers. Furthermore, the use of biomarkers in personalized medicines and drug discovery & development is expected to influence the growth in the market.

Artificial Intelligence

Northern Data Group platform, Peak Mining, announces purchase of a second 300MW data center location in Corpus Christi, Texas

Published

on

northern-data-group-platform,-peak-mining,-announces-purchase-of-a-second-300mw-data-center-location-in-corpus-christi,-texas

The location expands on an adjacent 300MW site, purchased in December 2023 The site comes with an ERCOT-approved interconnect of 300MWConstruction already underway, with long-lead time items secured and energization scheduled for early 2025FRANKFURT, Germany, May 24, 2024 /PRNewswire/ — Peak Mining, part of the Northern Data Group , announces the purchase of a second 300MW ERCOT-approved site in Corpus Christi, Texas. The location is adjacent to the 300MW mining facility that is already under construction. The site also provides energy in the attractive low-cost power zone of Load Zone South of the ERCOT grid, known for its abundance of renewable (wind) energy.

The investment represents a significant step forward in Northern Data Group’s investment strategy, cementing expansion plans well beyond the current 2024 financial year.
The new site enables Peak Mining to accelerate its expansion plans to become one of the largest bitcoin miners globally. The company will be deploying indoor, custom-designed, fully-integrated and liquid-cooled HPC data center systems to drastically improve deployment time and infrastructure cost, bringing Peak Mining to a leading position in the industry and preparing it for the future of HPC compute.
Saxet Infrastructure Group (“Saxet”) will act as construction manager for the design, build and energization of the substation. The Saxet team brings a strong track record of project management and deep expertise with the construction of HPC infrastructure.
Niek Beudeker, Managing Director of Northern Data Group Platform, Peak Mining, commented:
“The purchase of this second large site will significantly shorten our time to hashing and kick off one of the fastest mining expansions globally. We now have almost 700MW of sites in active development, that when fully fitted with our latest-generation hardware, could potentially provide up to 40EH of hash rate.”
Aroosh Thillainathan, Northern Data Group’s Chief Executive Officer, commented:
“This second data center location demonstrates how Northern Data Group is able to harness the power and opportunity of HPC. Sustainability has been at the core of this further expansion into the US and thanks to the center’s ERCOT approved status, we will be able to scale our operations at speed, as the demand for digital assets continues to grow.”
Steven Quisenberry, Chief Executive Officer at Saxet Infrastructure Group, commented: 
We are excited to support Northern Data Group’s expansion in the ERCOT market and specifically to welcome them to the Corpus Christi area.  The combination of base load industrial demand and significant renewable resources creates a unique opportunity for their portfolio.  This is a terrific example of one of the largest, most advanced liquid cooled data centers in North America and we are proud to partner with Northern Data Group to bring their data center online.
Northern Data Group was advised on the transaction by Katten Muchin Rosenman LLP (Legal Counsel) and BitOoda Technologies LLC.
About Peak Mining
Peak Mining, part of the Northern Data Group, is powering the future of the blockchain network.  We deliver industry-leading operating and energy efficiency in bitcoin mining through the latest hardware alongside innovative technology and infrastructure. With our mining heritage dating back to 2013, we’ve been innovating for over a decade and have been at the forefront of the industry ever since. Our high-quality infrastructure is purpose-built to power the mining network, and we’re driven to continuously find new efficiencies driving value for our investors. We’re delivering long term value in more responsible ways.
About Northern Data Group
Northern Data Group (ETR: NB2) is a leading provider of High Performance Computing (HPC) solutions to businesses and research institutions, utilizing GPU- and ASIC-based solutions. Our flexible compute power fuels innovation in our three core business platforms: Taiga Cloud, Ardent Data Centers, and Peak Mining. Through our HPC solutions, we pioneer ambitious computing innovation that drives progress in the AI, ML and Generative AI industries. Our close collaboration with industry-leading manufacturers including Gigabyte, AMD, and NVIDIA is fundamental to the acceleration of innovation across sectors including life sciences, financial services, and energy.  

View original content:https://www.prnewswire.co.uk/news-releases/northern-data-group-platform-peak-mining-announces-purchase-of-a-second-300mw-data-center-location-in-corpus-christi-texas-302154571.html

Continue Reading

Artificial Intelligence

Omnicom Media Group Expands Its Partnership with Lumen, Further Advancing Attention-Based Planning Capabilities Across Its Regions

Published

on

omnicom-media-group-expands-its-partnership-with-lumen,-further-advancing-attention-based-planning-capabilities-across-its-regions

LONDON, May 24, 2024 /PRNewswire/ — Omnicom Media Group (OMG) the media services division of leading global marketing and corporate communications holding company Omnicom Group Inc (NYSE: OMC) is expanding its market intelligence relationship with leading attention research company Lumen to now include data integration.

Under the terms of the agreement, attention data from the Lumen’s Attention Measurement Platform – which includes expected average viewing time and attentive seconds per thousand impressions – will be integrated into channel planning tools and processes within Omni, the open operating system that supports all Omnicom agencies. The addition of the Lumen attention benchmarks further advances OMG’s industry-leading attention-based planning capabilities, adding additional depth and breadth of insights to the existing attention datasets within Omni that enable attention to be leveraged as a KPI for media decisioning and creative optimization across OMG agencies OMD, PHD and Hearts & Science.
Over the past eight years, OMG has partnered with Lumen and other leading experts in attention measurement on hundreds of studies involving over 640,000 individuals worldwide, collecting nuanced attention benchmarks that offer invaluable insight into how content is consumed across various devices, channels, platforms, and formats. Activated within Omni, these datasets have enabled more precise channel selection tailored to the attention needs of individual campaigns.
“With the addition of the Lumen data, planning teams across OMG will have greater visibility into the attention value that each channel and format generates for their clients, ensuring optimal delivery of the right level of attention based on brand, brief and budget,” says OMG EMEA CEO Dan Clays.
Adds Mike Follett, CEO of Lumen, “The combination of Lumen’s attention data with OMG’s best-in-class Omni channel planning capabilities translates to a significant leap forward in leveraging attention to drive better outcomes for marketers.” 
About Omnicom Media Group  Omnicom Media Group (OMG), the media services division of Omnicom Group Inc. (NYSE: OMC), delivers transformational experiences for consumers, clients, and talent. Powered by the Omni marketing orchestration system, OMG connects best-in-class capabilities that enable our full-service media agencies OMD, PHD and Hearts & Science to deliver more relevant and actionable consumer experiences; more productive and proactive client experiences; and more collaborative and rewarding talent experiences for the more than 24,000 people serving the world’s leading brands in OMG agencies around the globe.
About Lumen ResearchLumen is the world’s leading attention technology company, with large-scale biometric datasets based on real-world and predictive eye-tracking technology that helps brands and agencies plan, buy and optimise media campaigns on the basis of human attention with creative, programmatic, and measurement solutions. Founded in 2013, Lumen is headquartered in London with offices in New York and LA.

View original content:https://www.prnewswire.co.uk/news-releases/omnicom-media-group-expands-its-partnership-with-lumen-further-advancing-attention-based-planning-capabilities-across-its-regions-302154915.html

Continue Reading

Artificial Intelligence

Picus Security Launches Security Validation for Kubernetes

Published

on

picus-security-launches-security-validation-for-kubernetes

Teams can eliminate container security exposures with the new enhancements in Picus’ platform for multi-cloud
SAN FRANCISCO, May 23, 2024 /PRNewswire/ — Picus Security, the Security Validation company, today announced security validation for Kubernetes. This new capability allows Security and DevOps teams to realize the benefits of containers securely by proactively measuring and optimizing the resilience of clusters. It is the latest innovative addition to the Picus Security Validation Platform, which empowers users to consistently validate their security posture and measure risk across on-premises and multi-cloud environments.

For organizations that want an agile way to deploy, run and scale applications, Kubernetes offers considerable benefits. However, security is often the biggest barrier to its adoption. The dynamic and complex nature of Kubernetes means that containers are often misconfigured due to human error. Without a hands-on approach to governance, security gaps can easily emerge over time, increasing the risk of incidents. This situation is exacerbated by the high level of expertise required to secure Kubernetes and the use of default settings which are inherently insecure. According to The State of Kubernetes Report, more than two-thirds of Kubernetes users (67%) have delayed deployments due to security concerns.* 
The addition of Kubernetes validation extends the Picus platform’s existing validation capabilities, which are powered by attack simulation and GenAI. It enables organizations to proactively identify and mitigate security misconfigurations, such as weak policies and settings that could allow containers to run with insecure privileges and facilitate lateral movement. Now security teams can automatically assess the security of their workloads wherever they are located – on-premises, in containers, and also in cloud platforms including Amazon Web Services, Google Cloud Platform, and Microsoft Azure.
“Cloud security is perhaps the biggest barrier of entry for organizations that want to take advantage of container orchestration,” said Volkan Erturk, Picus CTO and Co-Founder. “Kubernetes offers incredible opportunities for DevOps teams to deploy and scale new applications, but Security teams can struggle to keep pace.
“With the Picus Security Validation Platform, security concerns won’t slow down an organization’s digital transformation journey. This new offering will allow our users to consistently measure the security of their workloads and vastly reduce the effort needed to address exposures across growing IT environments.”
Additional Information
Read the Kubernetes validation announcement blog.Register for the upcoming webinar on July 11th 2024 at 10.00 EST/ 15.00 BST: Beyond Cloud Security Posture Management: Validating Cloud Effectiveness with Attack Simulation About Picus Security
Picus Security helps security teams consistently and accurately validate their security posture. Our Security Validation Platform simulates real-world threats to evaluate the effectiveness of security controls, identify high-risk attack paths to critical assets, and optimize threat prevention and detection capabilities.
As the pioneer of Breach and Attack Simulation, we specialize in delivering the actionable insights our customers need to be threat-centric and proactive. 
Picus is a Gartner® Peer Insights™ Customers’ Choice for 2024 in the BAS tools category†. The company is recognized as a leader by Frost & Sullivan^.
† Gartner, Voice of the Customer for Breach and Attack Simulation Tools, Peer Contributors, 30 January 2024 ^ Frost and Sullivan, 2022 Frost Radar™ report for the Global Breach and Attack Simulation Market
Logo: https://mma.prnewswire.com/media/2183222/4724563/Picus_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/picus-security-launches-security-validation-for-kubernetes-302154775.html

Continue Reading

Trending